Skip to main content
Log in

Gap acidosis except lactic acidosis develops and progresses during chronic kidney disease stage G5

  • Original article
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

Background

Gap acidosis, a type of metabolic acidosis caused by titratable acid accumulation, participates in CKD progression. It was found at all the stages of chronic kidney disease (CKD), whereas the kidney was believed to preserve its ability to excrete titratable acid until renal function is impaired severely.

Methods

Serum concentrations of lactate (Lac) and the other usually unmeasured anions (OUA) were separately examined using 420 records of blood gas analysis performed simultaneously with serum chemistry at a general hospital.

Results

Between the records grouped by the CKD stage, Lac was generally higher in the early stages than the late stages (2.2 ± 1.1, 1.9 ± 1.7, 1.5 ± 1.3, and 1.2 ± 0.6 mmol/L in G1–2, G3, G4, and G5, respectively). While OUA was not significantly different between G1–2, G3, and G4 (1.3 ± 2.0, 2.5 ± 2.7, and 2.6 ± 2.2 mEq/L, respectively), it was higher in G5 (4.7 ± 2.3 mEq/L) than in G1–4 (P < 0.001). In G5, OUA generally increased as eGFR decreased, and OUA was 6.6 ± 1.9, 4.7 ± 2.1 and 3.6 ± 2.0 mEq/L in subgroups of eGFR < 5, 5–10, and 10–15 mL/min/1.73 m2, respectively (P ≤ 0.001).

Conclusions

Gap acidosis except lactic acidosis developed and progressed during the CKD stage G5, while lactic acidosis developed in the CKD stages G1–4. Prevention of lactic acidosis by preserving peripheral perfusion in the early CKD stages could slow CKD progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Hamm LL, Nakhoul N, Hering-Smith KS. Acid–base homeostasis. Clin J Am Soc Nephrol. 2015;10:2232–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Kraut JA, Madias NE. Metabolic acidosis of CKD: an update. Am J Kidney Dis. 2016;67:307–17.

    Article  CAS  PubMed  Google Scholar 

  3. Nagami GT, Hamm LL. Regulation of acid–base balance in chronic kidney disease. Adv Chronic Kidney Dis. 2017;24:274–9.

    Article  PubMed  Google Scholar 

  4. Abramowitz MK, Hostetter TH, Melamed ML. Lower serum bicarbonate and a higher anion gap are associated with lower cardiorespiratory fitness in young adults. Kidney Int. 2012;81:1033–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Eustace JA, Astor B, Muntner PM, Ikizler TA, Coresh J. Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney Int. 2004;65:1031–40.

    Article  CAS  PubMed  Google Scholar 

  6. Phisitkul S, Khanna A, Simoni J, Broglio K, Sheather S, Rajab MH, Wesson DE. Amelioration of metabolic acidosis in patients with low GFR reduced kidney endothelin production and kidney injury, and better preserved GFR. Kidney Int. 2010;77:617–23.

    Article  CAS  PubMed  Google Scholar 

  7. de Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM. Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol. 2009;20:2075–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Berend K, de Vries AP, Gans RO. Physiological approach to assessment of acid–base disturbances. N Engl J Med. 2014;371:1434–45.

    Article  CAS  PubMed  Google Scholar 

  9. Phisitkul S, Hacker C, Simoni J, Tran RM, Wesson DE. Dietary protein causes a decline in the glomerular filtration rate of the remnant kidney mediated by metabolic acidosis and endothelin receptors. Kidney Int. 2008;73:192–9.

    Article  CAS  PubMed  Google Scholar 

  10. Hakim RM, Lazarus JM. Biochemical parameters in chronic renal failure. Am J Kidney Dis. 1988;11:238–47.

    Article  CAS  PubMed  Google Scholar 

  11. Abramowitz MK, Hostetter TH, Melamed ML. The serum anion gap is altered in early kidney disease and associates with mortality. Kidney Int. 2012;82:701–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Kraut JA, Madias NE. Lactic acidosis. N Engl J Med. 2014;371:2309–19.

    Article  CAS  PubMed  Google Scholar 

  13. Kraut JA, Xing SX. Approach to the evaluation of a patient with an increased serum osmolal gap and high-anion-gap metabolic acidosis. Am J Kidney Dis. 2011;58:480–4.

    Article  PubMed  Google Scholar 

  14. Morris CG, Low J. Metabolic acidosis in the critically ill: part 2. Causes and treatment. Anaesthesia. 2008;63:396–411.

    Article  CAS  PubMed  Google Scholar 

  15. Figge J, Jabor A, Kazda A, Fencl V. Anion gap and hypoalbuminemia. Crit Care Med. 1998;26:1807–10.

    Article  CAS  PubMed  Google Scholar 

  16. Carvounis CP, Feinfeld DA. A simple estimate of the effect of the serum albumin level on the anion gap. Am J Nephrol. 2000;20:369–72.

    Article  CAS  PubMed  Google Scholar 

  17. Feldman M, Soni N Dickson B. Influence of hypoalbuminemia or hyperalbuminemia on the serum anion gap. J Lab Clin Med. 2005;46:317−20.

  18. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A; Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982−92.

  19. Widmer B, Gerhardt RE, Harrington JT, Cohen JJ. Serum electrolyte and acid base–composition. The influence of graded degrees of chronic renal failure. Arch Intern Med. 1979;139:1099–102.

    Article  CAS  PubMed  Google Scholar 

  20. Wallia R, Greenberg A, Piraino B, et al. Serum electrolyte patterns in endstage renal disease. Am J Kidney Dis. 1986;8:98–104.

    Article  CAS  PubMed  Google Scholar 

  21. Hsu CY, Chertow GM. Elevations of serum phosphorus and potassium in mild to moderate chronic renal insufficiency. Nephrol Dial Transplant. 2002;17:1419–25.

    Article  CAS  PubMed  Google Scholar 

  22. Remer T. Influence of nutrition on acid–base balance–metabolic aspects. Eur J Nutr. 2001;40:214–20.

    Article  CAS  PubMed  Google Scholar 

  23. Toyohara T, Akiyama Y, Suzuki T, Takeuchi Y, Mishima E, Tanemoto M, Momose A, Toki N, Sato H, Nakayama M, Hozawa A, Tsuji I, Ito S, Soga T, Abe T. Metabolomic profiling of uremic solutes in CKD patients. Hypertens Res. 2010;33:944–52.

    Article  PubMed  Google Scholar 

  24. Spiegel DM. Magnesium in chronic kidney disease: unanswered questions. Blood Purif. 2011;31:172–6.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masayuki Tanemoto.

Ethics declarations

Conflict of interest

The author has no conflicts of interest to declare.

Ethical standards

The study was conducted in accordance with the guidelines written in the Declaration of Helsinki. The study was approved by the ethics committee of Shin-Kuki General Hospital (Approved number 0002) and written informed consent from individual patients was waived.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tanemoto, M. Gap acidosis except lactic acidosis develops and progresses during chronic kidney disease stage G5. Clin Exp Nephrol 23, 1045–1049 (2019). https://doi.org/10.1007/s10157-019-01743-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-019-01743-4

Keywords

Navigation